Clinical Immunology Current Events | Clinical Immunology News | 6
|
| Page
6 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
Limiting damage after heart transplantation
Scientists from Imperial College School of Medicine at Harefield Hospital may have found a way of dampening down damaging immune responses following heart transplants. Professor Rose will describe her work at the British Society for Immunology’s Congress 2000 in Harrogate today (Thursday 7 December 2000). World-wide, 5,000 heart transplants... view more... (2000-12-01)
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for... view more... (2008-07-10)
Brisbane teens receive first cancer vaccine shots
UQ Professor Ian Frazer administered the first shots of the cervical cancer vaccine Gardasil in Queensland this afternoon at the Princess Alexandra Hospital. view more (2006-08-29)
Highlights of leading allergy and immunology research presented for first time at BSI/BSACI congress
Today marks the opening of the Annual Meeting of British Society for Immunology (BSI) and the British Society for Allergy & Clinical Immunology (BSACI) congress - hot new research covers future therapeutic possibilities for Creutzfeldt-Jakob disease, research that aspirin may lead to life-threatening reactions in certain types of asthma, cats... view more... (2002-12-19)
A MANAGEMENT PLAN FOR PATIENTS WITH NUT ALLERGIES (pp 87, 111)
In this week’s issue of THE LANCET, researchers from Cambridge, UK, report the success of a newly designed management strategy for people with potentially fatal allergies to peanuts and other nuts. Despite the high level of media attention given to nut allergies, little is known about the clinical features of such disorders, and strategies... view more... (2001-01-11)
Trainee Clinical Psychologists Show Their Worth
Trainee clinical psychologists working under supervision, within the context of a clinical placement can treat clients as successfully as their fully qualified colleagues. These findings are reported today, Thursday 15 April 2004, by Jessica Buckley of St Luke's Hospital, Huddersfield, at the Annual Conference of the British Psychological... view more... (2004-04-15)
Effective mentoring critical to HIV/AIDS research efforts
An innovative mentoring program at the UCSF-Gladstone Institute for Virology and Immunology Center for AIDS Research is providing vital support for the development of the next generation of HIV/AIDS researchers and clinician scientists. view more (2009-02-27)
Nerve Centre Opens in Manchester: media invitation
Research which will greatly improve patient recovery from nerve damage following accidents, will take a major step forward with the opening of dedicated laboratories at The University of Manchester on Thursday 13 November at 2.30pm. The Blond McIndoe Nerve Regeneration Group, formerly based at The Royal Free and University College Medical School,... view more... (2003-11-12)
Immunotherapy for Cancer: Inflammations Open up Access to Tumours
Although the immune system potentially recognizes tumour cells as foreign and destroys them, vaccination therapies have so far been disappointing. Malignant tumours seem to establish a special environment that blocks access for immune cells. However, an experimentally induced inflammation can overcome the tumour's intrinsic resistance for... view more... (2004-05-13)
International study investigates early biology of HIV infection
In July 2005, the race to find a vaccine that would stem the worldwide rate of 13,000 new cases of HIV infection each day moved from competition among research institutions to a strategy of cooperation. view more (2006-05-02)
Researchers discover new battleground for viruses and immune cells
Vaccines have led to many of the world's greatest public health triumphs, but many deadly viruses, such as HIV, still elude the best efforts of scientists to develop effective vaccines against them. view more (2008-02-07)
Scientists discover how deadly fungus protects itself
Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how a deadly microbe evades the human immune system and causes disease. view more (2009-02-04)
Vaccine shown effective against chancroid
HIV plagues more than 25 million people in sub-Saharan Africa, according to the World Health Organization, and efforts to develop a vaccine against the virus have achieved limited success. view more (2006-05-08)
Study reveals link among childhood allergies, asthma symptoms, and early life exposure to cats
A study released by researchers at the Columbia Center for Children's Environmental Health (CCCEH) at Columbia University's Mailman School of Public Health, shows that cat ownership may have a protective effect against the development of asthma symptoms in young children at age five. view more (2008-05-21)
Vaccine for stomach flu may be possible, UNC research shows
Every year, millions of people are infected with noroviruses - commonly called "stomach flu" - often resulting in up to 72 hours of vomiting and diarrhea. While most people recover in a few days, the symptoms can lead to dehydration and - in rare cases, especially among the elderly and infants - death. view more (2008-02-14)
Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
Heart disease is the leading cause of death in the United States and greatly affects the quality and length of life for individuals with specific forms of muscular dystrophy. view more (2007-11-01)
Two centres for infectious diseases established
The Netherlands Organisation for Scientific Research (NWO) has awarded a so-called centre subsidy to two research centres which are currently being established. Each centre will receive a total of 1.35 million euros. These funds must be used by the centres over the next five years to carry out multidisciplinary research towards the prevention,... view more... (2004-02-05)
Research team develops cancer-curing T-lymphocyte-based therapy to eradicate malignant tumours
Research in Immunology and Cancer (IRIC) of the Université de Montréal, has succeeded in developing a new approach to eradicate malignant melanoma tumours in mice. view more (2005-10-19)
Immune Cell Communication, Cooperation Keys to Hunting Viruses, Jefferson Immunologists Show
Immunologists at the Kimmel Cancer Center at Thomas Jefferson University in Philadelphia have used nanotechnology to create a novel 'biosensor' to solve in part a perplexing problem in immunology: how immune system cells called killer T-cells hunt down invading viruses. view more (2006-10-27)
New vaccine platform may fight infections with causes from influenza to bioterrorism
The development of effective vaccines for people with compromised immune systems may be feasible after all, according to a team of researchers, who demonstrated their approach could protect against pneumocystis pneumonia in mice lacking the same population of immune cells that HIV destroys in humans. view more (2005-11-28)
|
|
| Page
6 of
13 |
256 Results |
|
|
|
Sort By:
Page Views | Date |
|
